Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease

被引：3
|
作者：
Cherney, David Z. I. L. [1 ,7 ]
Bhatt, Deepak [2 ]
Szarek, Michael [3 ]
Sun, Franklin [4 ]
Girard, Manon J. [4 ]
Davies, Michael [4 ]
Pitt, Bertram [5 ]
Steg, Ph. Gabriel [6 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Mt Sinai Hlth Syst, Mt Sinai Heart, Icahn Sch Med, New York, NY USA
[3] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[4] Lexicon Pharmaceut Inc, The Woodlands, TX USA
[5] Univ Michigan, Ann Arbor, MI USA
[6] Univ Paris Cite, Hop Bichat, AP HP, INSERM U 1148, Paris, France
[7] Toronto Gen Hosp, 85 Univ Ave,8N 845, Toronto, ON M5G 2N2, Canada
来源：
DIABETES OBESITY & METABOLISM | 2023年 / 25卷 / 11期
关键词：
D O I：
10.1111/dom.15203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3410 / 3414
页数：5
相关论文
共 50 条
  • [41] Effects of Alogliptin in Chronic Kidney Disease Patients with Type 2 Diabetes
    Sakai, Yukinao
    Suzuki, Anna
    Mugishima, Koji
    Sumi, Yuichiro
    Otsuka, Yusuke
    Otsuka, Tomoyuki
    Ohno, Dai
    Murasawa, Tsuneo
    Tsuruoka, Shuichi
    INTERNAL MEDICINE, 2014, 53 (03) : 195 - 203
  • [42] Effect of semaglutide on chronic kidney disease in patients with type 2 diabetes: An analysis of the FLOW study
    Feldkamp, Thorsten
    NEPHROLOGIE, 2024, 19 (06): : 367 - 369
  • [43] EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD
    Abdullaev, Sherzod
    Sharapov, Olimkhon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I685 - I686
  • [44] Inappropriate Body Weight Management and Highly Prevalent Chronic Kidney Disease Without Albuminuria among Japanese Type 2 Diabetes Patients
    Okuguchi, Fuminobu
    Kaise, Toshihiko
    Oishi, Mariko
    Sugimoto, Hidekatsu
    Hirao, Koichi
    Kawai, Koichi
    Kobayashi, Masashi
    Kashiwagi, Atsunori
    DIABETES, 2012, 61 : A663 - A663
  • [45] Effects of Low Muscle Mass on Albuminuria and Chronic Kidney Disease in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS)
    Chung, Hye Soo
    Hwang, Soon Young
    Choi, Ju Hee
    Lee, Hyun Jung
    Yoo, Hye Jin
    Seo, Ji-A
    Kim, Sin Gon
    Kim, Nan Hee
    Choi, Dong Seop
    Baik, Sei Hyun
    Choi, Kyung Mook
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2018, 73 (03): : 386 - 392
  • [46] Implication of low muscle mass on albuminuria and chronic kidney disease in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)
    Chung, H.
    Lee, H.
    Yoo, H.
    Seo, J. -A.
    Kim, S.
    Kim, N.
    Baik, S.
    Choi, D.
    Choi, K.
    DIABETOLOGIA, 2016, 59 : S109 - S110
  • [47] DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE DAPA-CKD TRIAL
    Jong, Niels
    Chertow, Glenn
    Hou, Fan Fan
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur
    Toto, Robert
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo Lambers
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [48] Prevalence of raised intact parathyroid hormone levels in patients with type 2 diabetes, history of albuminuria and stage 3 chronic kidney disease
    Clarkson-Dodd, B.
    Saravanai-Prabu, K.
    Osborne, C.
    Patel, D.
    Patel, P.
    Thomas, S.
    Gnudi, L.
    Karalliedde, J.
    DIABETIC MEDICINE, 2013, 30 : 69 - 69
  • [49] Association of Race/Ethnicity, Inflammation, and Albuminuria in Patients With Diabetes and Early Chronic Kidney Disease
    Sinha, Satyesh K.
    Shaheen, Magda
    Rajavashisth, Tripathi B.
    Pan, Deyu
    Norris, Keith C.
    Nicholas, Susanne B.
    DIABETES CARE, 2014, 37 (04) : 1060 - 1068
  • [50] TYPE 2 DIABETES, CHRONIC KIDNEY DISEASE, AND MORTALITY IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Rein, Philipp
    Muendlein, Axel
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1841 - 1841
12345